Clinical Trial Update: Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial update assessing subcutaneous continuous infusion of Interferon alfa-2b with Ribavirin in genotype 1 chronic hepatitis C nonresponde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED